Clinical Trials Directory

Trials / Sponsors / Hellenic Society of Hematology

Hellenic Society of Hematology

Academic / Other · 11 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIE
Primary Immune Thrombocytopenia (ITP)
Phase 22025-06-20
RecruitingA Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide,
Multiple Myeloma, Neoplasms, Neoplasm, Plasma Cell
Phase 1 / Phase 22023-07-14
Not Yet RecruitingA Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma
Multiple Myeloma, Multiple Myeloma in Relapse, Neoplasms
Phase 1 / Phase 22022-10-20
UnknownA Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received O
Multiple Myeloma, Renal Impairment, Neoplasms, Plasma Cell
Phase 22022-05-01
UnknownA Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma
Multiple Myeloma, Neoplasms, Neoplasms, Plasma Cell
Phase 1 / Phase 22022-04-13
UnknownA Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by I
Multiple Myeloma, Renal Impairment, Neoplasms, Plasma Cell
Phase 22022-04-01
RecruitingAn Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evalua
Primary Plasma Cell Leukemia
Phase 22021-11-19
Active Not RecruitingBlmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22021-02-22
UnknownSafety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or
Multiple Myeloma
Phase 22018-12-01
UnknownEffects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple My
Multiple Myeloma
Phase 22018-02-21
CompletedEfficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
Relapsed/Refractory Multiple Myeloma
Phase 22018-02-15